Statin uncertainty laid to rest by major review

A comprehensive scientific review in The Lancet that balances the harms and benefits of statins will help clinicians and their patients make informed decisions about the drug class.  The review of the literature by researchers who have made substantial contributions to the science of statins concludes that lowering cholesterol by 2 mmol/L with an effective ...

Already a member?

Login to keep reading.

© 2021 the limbic